Praxis Precision Medicines (NASDAQ:PRAX) Price Target Raised to $28.00 at Wedbush
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective upped by analysts at Wedbush from $26.00 to $28.00 in a report released on Monday,Benzinga reports. The firm presently has an “underperform” rating on the stock. Wedbush’s price target indicates a potential downside of 20.39% from the company’s previous close. Wedbush also issued […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective upped by analysts at Wedbush from $26.00 to $28.00 in a report released on Monday,Benzinga reports. The firm presently has an “underperform” rating on the stock. Wedbush’s price target indicates a potential downside of 20.39% from the company’s previous close. Wedbush also issued […]
